ATHA Latest Press Releases

-- December 18, 2025 --

Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million Globe Newswire 7:02 AM

-- November 6, 2025 --

Athira Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- September 11, 2025 --

Athira Pharma Announces Reverse Stock Split Globe Newswire 9:00 AM

-- August 14, 2025 --

Athira Pharma Presents ATH-1105 Phase 1 Trial Results at ALS Nexus 2025 Globe Newswire 7:00 AM

-- August 7, 2025 --

Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software